Literature DB >> 10719749

Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis.

H Matsuda1, Y Fujiyama, A Andoh, T Ushijima, T Kajinami, T Bamba.   

Abstract

BACKGROUND: Previous reports on faecal microflora have demonstrated that the total number of aerobes and coliforms was increased in patients with ulcerative colitis (UC). Based on the hypothesis that the pathogenesis of UC may be closely associated with the mucosal microflora, we investigated alterations in the mucosa-associated microflora of UC patients. METHODS AND
RESULTS: The bacterial counts for both aerobes and anaerobes increased in UC patients. In particular, we detected the highest bacterial counts of Bacteroides vulgatus and these bacteria were isolated most frequently. In addition, we also investigated the serum antibody responses against the bacteria isolated from the affected mucosa by serum bacterial agglutination tests and immunoblotting. A high agglutination titre against B. vulgatus, Bacteroides fragilis, and Clostridium ramosum was detected in most UC patients, and the percentage of positive immunoreactivity was much higher in UC patients than in healthy controls. From the results of the immunoblotting, a unique antigenic determinant of B. vulgatus (BV43-26), a 26-kDa protein from the outer membrane, was discovered. The serum immunoreactivity (immunoglobulin (Ig) G) against this 26-kDa protein was much higher in UC patients (53.8%) than in the control sera (9.1%). The serum immunoreactivity (IgG) against a 50-kDa protein isolated from the whole cell protein of Escherichia coli (EC48-1) was also higher in UC patients (29.2%) than in normal controls (6.3%).
CONCLUSIONS: These results suggest that B. vulgatus and a specific antibody response directed against it may play an important role in the pathogenesis of UC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10719749     DOI: 10.1046/j.1440-1746.2000.02045.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  41 in total

Review 1.  Probiotics and inflammatory bowel disease.

Authors:  Daisy Jonkers; Reinhold Stockbrügger
Journal:  J R Soc Med       Date:  2003-04       Impact factor: 5.344

Review 2.  Regulation of epithelial cell functions by the intestinal milieu.

Authors:  Tadao Bamba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

3.  Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis.

Authors:  Hideyuki Nemoto; Keiko Kataoka; Hideki Ishikawa; Kazue Ikata; Hideki Arimochi; Teruaki Iwasaki; Yoshinari Ohnishi; Tomomi Kuwahara; Koji Yasutomo
Journal:  Dig Dis Sci       Date:  2012-05-24       Impact factor: 3.199

Review 4.  Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.

Authors:  Akira Andoh; Yoshihide Fujiyama
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

5.  Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease.

Authors:  Akira Andoh; Hiroyuki Kuzuoka; Tomoyuki Tsujikawa; Shiro Nakamura; Fumihito Hirai; Yasuo Suzuki; Toshiyuki Matsui; Yoshihide Fujiyama; Takayuki Matsumoto
Journal:  J Gastroenterol       Date:  2012-05-11       Impact factor: 7.527

Review 6.  Microbial host interactions in IBD: implications for pathogenesis and therapy.

Authors:  R Balfour Sartor; Marcus Muehlbauer
Journal:  Curr Gastroenterol Rep       Date:  2007-12

7.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

8.  Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.

Authors:  E Furrie; S Macfarlane; J H Cummings; G T Macfarlane
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

9.  Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice.

Authors:  Jingxiao Ye; Jimmy W Lee; Laura L Presley; Elizabeth Bent; Bo Wei; Jonathan Braun; Neal L Schiller; Daniel S Straus; James Borneman
Journal:  Inflamm Bowel Dis       Date:  2008-08       Impact factor: 5.325

10.  Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial.

Authors:  Osamu Kanauchi; Toshihiro Suga; Masahiro Tochihara; Toshifumi Hibi; Makoto Naganuma; Terasu Homma; Hitoshi Asakura; Hiroshi Nakano; Kazuya Takahama; Yoshihide Fujiyama; Akira Andoh; Takashi Shimoyama; Nobuyuki Hida; Ken Haruma; Hideki Koga; Keiichi Mitsuyama; Michio Sata; Masanobu Fukuda; Atsushi Kojima; Tadao Bamba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.